315 related articles for article (PubMed ID: 29524132)
21. Regulation of Gene Expression Using dCas9-SunTag Platforms.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2023; 2577():189-195. PubMed ID: 36173574
[TBL] [Abstract][Full Text] [Related]
22. Targeting oncogenic TERT promoter variants by allele-specific epigenome editing.
Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
[TBL] [Abstract][Full Text] [Related]
23. Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges.
Ueda J; Yamazaki T; Funakoshi H
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902207
[TBL] [Abstract][Full Text] [Related]
24.
Liang F; Dong Z; Ye J; Hu W; Bhandari RK; Mai K; Wang X
Epigenetics; 2023 Dec; 18(1):2192326. PubMed ID: 36945831
[TBL] [Abstract][Full Text] [Related]
25. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
[TBL] [Abstract][Full Text] [Related]
26. Allele-specific genome targeting in the development of precision medicine.
Wu J; Tang B; Tang Y
Theranostics; 2020; 10(7):3118-3137. PubMed ID: 32194858
[TBL] [Abstract][Full Text] [Related]
27. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
28. Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
Gemberling MP; Siklenka K; Rodriguez E; Tonn-Eisinger KR; Barrera A; Liu F; Kantor A; Li L; Cigliola V; Hazlett MF; Williams CA; Bartelt LC; Madigan VJ; Bodle JC; Daniels H; Rouse DC; Hilton IB; Asokan A; Ciofani M; Poss KD; Reddy TE; West AE; Gersbach CA
Nat Methods; 2021 Aug; 18(8):965-974. PubMed ID: 34341582
[TBL] [Abstract][Full Text] [Related]
29. Editing the Epigenome: Reshaping the Genomic Landscape.
Holtzman L; Gersbach CA
Annu Rev Genomics Hum Genet; 2018 Aug; 19():43-71. PubMed ID: 29852072
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
31. Epigenome engineering: new technologies for precision medicine.
Sgro A; Blancafort P
Nucleic Acids Res; 2020 Dec; 48(22):12453-12482. PubMed ID: 33196851
[TBL] [Abstract][Full Text] [Related]
32. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems.
Papikian A; Liu W; Gallego-Bartolomé J; Jacobsen SE
Nat Commun; 2019 Feb; 10(1):729. PubMed ID: 30760722
[TBL] [Abstract][Full Text] [Related]
33. Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants.
Fal K; Tomkova D; Vachon G; Chabouté ME; Berr A; Carles CC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419220
[TBL] [Abstract][Full Text] [Related]
34. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
Bae T; Hur JW; Kim D; Hur JK
Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
[TBL] [Abstract][Full Text] [Related]
35. Concurrent genome and epigenome editing by CRISPR-mediated sequence replacement.
Alexander J; Findlay GM; Kircher M; Shendure J
BMC Biol; 2019 Nov; 17(1):90. PubMed ID: 31739790
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9-Based Engineering of the Epigenome.
Pulecio J; Verma N; Mejía-Ramírez E; Huangfu D; Raya A
Cell Stem Cell; 2017 Oct; 21(4):431-447. PubMed ID: 28985525
[TBL] [Abstract][Full Text] [Related]
37. Generation of TALE-Based Designer Epigenome Modifiers.
Nitsch S; Mussolino C
Methods Mol Biol; 2018; 1767():89-109. PubMed ID: 29524130
[TBL] [Abstract][Full Text] [Related]
38. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
Nguyen TV; Lister R
Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.
Pacheco MB; Camilo V; Henrique R; Jerónimo C
Epigenetics; 2022 May; 17(5):564-588. PubMed ID: 34130596
[TBL] [Abstract][Full Text] [Related]
40. A modular dCas9-based recruitment platform for combinatorial epigenome editing.
Swain T; Pflueger C; Freytag S; Poppe D; Pflueger J; Nguyen TV; Li JK; Lister R
Nucleic Acids Res; 2024 Jan; 52(1):474-491. PubMed ID: 38000387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
